Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

被引：0
|
作者：
Rosas, I. [1 ]
Solomon, J. [2 ]
Donoff, S. [3 ]
Woodhead, F. [4 ]
Raghu, G. [5 ]
Hilary, G. [6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Univ Leicester, Leicester, Leics, England
[5] Univ Washington, Seattle, WA 98195 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] TRAIL NETWORK, Seattle, WA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4534
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4534
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
    Nyhlin, H
    Bang, C
    Elsborg, L
    Silvennoinen, J
    Holme, I
    Rüegg, P
    Jones, J
    Wagner, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (02) : 119 - 126
  • [42] Efficacy and safety of plecanatide in Chinese patients with functional constipation: A phase III randomized, double-blinded, placebo-controlled, multicenter trial
    Bai, Tao
    Xu, Zhiyue
    Jiang, Yueping
    Zhao, Hong
    Yan, Peng
    Dai, Ning
    Chen, Xi
    Huang, Kunming
    Cui, Jun
    Xu, Min
    Jia, Shujuan
    Zhang, Juan
    Liu, Side
    Li, Xiaoqing
    Ai, Yaowei
    Zhang, Mingxin
    Wu, Yongdong
    Zhou, Weizhen
    Zhao, Rong
    Wu, Jianjun
    Wang, Bangmao
    Xu, Baohong
    Ding, Xiangwu
    Fang, Xiangming
    Yang, Shaoqi
    Ma, Yingcai
    Zhou, Zhongyin
    Lin, Lin
    Chen, Huixin
    Zhang, Heng
    Zhu, Yin
    Jiang, Bo
    Zhang, Xiaolan
    Wang, Xiaoyan
    Zou, Duowu
    Ye, Bin
    Zhang, Ling
    Shi, Ruihua
    Zhen, Yanbo
    Wang, Junping
    Liu, Youli
    Liao, Aijun
    Hou, Xiaohua
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36
  • [43] Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis: Results of a randomized double-blind study
    Geusen, P
    Alten, R
    Rovensky, J
    Sloan, V
    Krammer, G
    Kralidis, G
    Richardson, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S242 - S242
  • [44] Safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of WBP216, a novel IL-6 monoclonal antibody, in patients with rheumatoid arthritis: A phase Ia randomized placebo-controlled study
    Leng, Xiaomei
    Tang, Xiange
    Hu, Pei
    Guan, Xiaoduo
    Li, Qian
    Huang, Cipo
    Zhang, Qiang
    Chen, Rui
    Zeng, Xiaofeng
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [45] Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial
    Lu Liang-Jing
    Teng Jia-Lin
    Bao Chun-De
    Han Xing-Hai
    Sun Ling-Yun
    Xu Jiang-Hua
    Li Xing-Fu
    Wu Hua-Xiang
    CHINESE MEDICAL JOURNAL, 2008, 121 (07) : 615 - 619
  • [46] Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
    Hobbs, Kathryn
    Deodhar, Atul
    Wang, Brian
    Bitman, Bojena
    Nussbaum, Joyce
    Chung, James
    Collier, David H.
    SPRINGERPLUS, 2015, 4 : 1 - 7
  • [47] A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
    Snowden, JA
    Biggs, JC
    Milliken, ST
    Fuller, A
    Staniforth, D
    Passuello, F
    Renwick, J
    Brooks, PM
    BONE MARROW TRANSPLANTATION, 1998, 22 (11) : 1035 - 1041
  • [48] Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial
    Yoshimoto, Takeshi
    Saito, Satoshi
    Omae, Katsuhiro
    Tanaka, Kenta
    Kita, Toshihiro
    Kitamura, Kazuo
    Fukuma, Kazuki
    Washida, Kazuo
    Abe, Soichiro
    Ishiyama, Hiroyuki
    Yamaguchi, Eriko
    Yamagami, Hiroshi
    Nagatsuka, Kazuyuki
    Tsuji, Masahiro
    Minami, Manabu
    Yamamoto, Haruko
    Hattori, Yorito
    Tanaka, Tomotaka
    Ihara, Masafumi
    ECLINICALMEDICINE, 2024, 77
  • [49] A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
    JA Snowden
    JC Biggs
    ST Milliken
    A Fuller
    D Staniforth
    F Passuello
    J Renwick
    PM Brooks
    Bone Marrow Transplantation, 1998, 22 : 1035 - 1041
  • [50] RETRACTED: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS (Retracted Article)
    Leber, Andrew
    Hontecillas, Raquel
    Tubau-Juni, Nuria
    Lichtiger, Simon
    Bassaganya-Riera, Josep
    GASTROENTEROLOGY, 2022, 162 (03) : S112 - S112
12345